GB0812031D0 - Thiazole derivatives - Google Patents
Thiazole derivativesInfo
- Publication number
- GB0812031D0 GB0812031D0 GBGB0812031.3A GB0812031A GB0812031D0 GB 0812031 D0 GB0812031 D0 GB 0812031D0 GB 0812031 A GB0812031 A GB 0812031A GB 0812031 D0 GB0812031 D0 GB 0812031D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- thiazole derivatives
- thiazole
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0812031.3A GB0812031D0 (en) | 2008-07-01 | 2008-07-01 | Thiazole derivatives |
| PCT/GB2009/050770 WO2010001166A1 (fr) | 2008-07-01 | 2009-07-01 | Dérivés de thiazole en tant que modulateurs du gpr 119 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0812031.3A GB0812031D0 (en) | 2008-07-01 | 2008-07-01 | Thiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0812031D0 true GB0812031D0 (en) | 2008-08-06 |
Family
ID=39707838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0812031.3A Ceased GB0812031D0 (en) | 2008-07-01 | 2008-07-01 | Thiazole derivatives |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0812031D0 (fr) |
| WO (1) | WO2010001166A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2146210A1 (fr) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Procédés d'utilisation du récepteur couplé aux protéines A G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement d'états modulés par PYY |
| EP2937345B1 (fr) | 2009-12-29 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de la kinase raf de type ii |
| JP2013522279A (ja) | 2010-03-18 | 2013-06-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連状態の治療で用いるgpr119作動薬とddp−iv阻害薬リナグリプチンの組合せ |
| GB201006166D0 (en) | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB201006167D0 (en) | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| TW201209054A (en) | 2010-05-28 | 2012-03-01 | Prosidion Ltd | Novel compounds |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| GB201114389D0 (en) | 2011-08-22 | 2011-10-05 | Prosidion Ltd | Novel compounds |
| WO2012066077A1 (fr) | 2010-11-18 | 2012-05-24 | Prosidion Limited | Dérivés 1,4 di substitués pyrolidine-3-yl-amine et leur utilisation pour le traitement de troubles métaboliques |
| WO2014011926A1 (fr) | 2012-07-11 | 2014-01-16 | Elcelyx Therapeutics, Inc. | Compositions comportant des statines, des biguanides et d'autres agents pour réduire un risque cardiométabolique |
| EP2718279B1 (fr) | 2011-06-09 | 2016-08-10 | Rhizen Pharmaceuticals SA | Composés nouveaux comme modulateurs de la gpr119 |
| WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
| WO2013045413A1 (fr) | 2011-09-27 | 2013-04-04 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| US10870651B2 (en) | 2014-12-23 | 2020-12-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| AU2016243529B2 (en) | 2015-03-27 | 2021-03-25 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| EP4019515A1 (fr) * | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinases cycline-dépendantes |
| WO2020005807A1 (fr) | 2018-06-25 | 2020-01-02 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinase de la famille taire et utilisations correspondantes |
-
2008
- 2008-07-01 GB GBGB0812031.3A patent/GB0812031D0/en not_active Ceased
-
2009
- 2009-07-01 WO PCT/GB2009/050770 patent/WO2010001166A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010001166A1 (fr) | 2010-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0812031D0 (en) | Thiazole derivatives | |
| IL210548A0 (en) | Spiroaminodihydrothiazine derivatives | |
| ZA201100799B (en) | Imidazopyridin-2-one derivatives | |
| IL200329A0 (en) | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives | |
| IL205751A0 (en) | Aminothiazole derivatives | |
| SG10201506608RA (en) | 3-deazaneplanocin derivatives | |
| IL202020A0 (en) | Spiroindolinone derivatives | |
| ZA201100876B (en) | Pyrrolopyridinylpyrimidin-2-ylamine derivatives | |
| IL208203A0 (en) | Heterocyclic derivatives | |
| ZA201102449B (en) | Morpholinopurine derivatives | |
| IL204563A0 (en) | Thiazole derivatives | |
| IL210869A0 (en) | Imidazothiadiazoles derivatives | |
| IL208336A0 (en) | Pyrisazinone derivatives | |
| IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
| IL195007A0 (en) | Thiazole derivatives | |
| ZA201101236B (en) | New 2-amidothiadiazole derivatives | |
| ZA201100948B (en) | Acylaminobenzamide derivatives | |
| IL210164A0 (en) | Thiazolylpiperidine derivatives | |
| ZA201005382B (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| IL213424A0 (en) | Quinazolinamide derivatives | |
| IL207191A0 (en) | Substituted heteroaylamide oxazepyrimidone derivatives | |
| ZA201008052B (en) | 2-phenyl-4-cyclopropyl-pyrimidine derivatives | |
| PL2220060T3 (pl) | Pochodne tetrahydrobenzotiazolu | |
| EP2133347A4 (fr) | Dérivés de 1-biarylazétidinone | |
| IL202159A (en) | History of Pipridine-affluent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application |
Owner name: PROSIDION LIMITED Free format text: FORMER OWNER: 7TM PHARMA A/S |
|
| AT | Applications terminated before publication under section 16(1) |